DRUG LICENSE AND DEVELOPMENT AGREEMENT by and between LANTERN PHARMA, INC. and ONCOLOGY VENTURE, APSDrug License and Development Agreement • April 16th, 2020 • Lantern Pharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 16th, 2020 Company Industry JurisdictionThis Drug License And Development Agreement (the “Agreement”) is entered into and effective as of May 23, 2015 (the “Effective Date”) by and between Oncology Venture Aps, (Company Registration no. 34 62 35 62) a Danish corporation having its principal offices at Venlighedesvej 1, 2970 Hørsholm, Denmark (“OV”), and Lantern Pharma, Inc, (Company Registration no. __________________________) a Texas corporation